A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer

By O’Connor R.   O’Leary M.   Ballot J.   Collins C.   Kinsella P.   Mager D.   Arnold R.   O’Driscoll L.   Larkin A.   Kennedy S.   Fennelly D.   Clynes M.   Crown J.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 79-87

Springer Publishing Company

Access to resources Recommend Favorite

Multidrug Resistance Gene-1 Is a Useful Predictor of Paclitaxel-Based Chemotherapy for Patients with Ovarian Cancer

By Kamazawa S.   Kigawa J.   Kanamori Y.   Itamochi H.   Sato S.   Iba T.   Terakawa N.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 171-176

Academic Press

Access to resources Recommend Favorite

Studies on the Relationship between Multidrug Resistance 1 Gene and Pancreatic Cancer

By Wang Bailin   Xiao Zhenyu   Chen Xiaoping   Zhai Shuping  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 15-19

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of a New Gene p28GANK Confers Multidrug Resistance of Gastric Cancer Cells

By Li Xiaohua   Zhang Ying   Xiong Chen   Jin Haifeng   Jing Bin   Zhang Yafei   Fan Daiming  

Cancer Investigation, Vol. 27, Iss. 2, 2009-02 ,pp. : 129-139

Informa Healthcare

Access to resources Recommend Favorite

Expression of the multidrug resistance gene in human prostate cancer

By Bhangal G.   Halford S.   Wang J.   Roylance R.   Shah R.   Waxman J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 3, 2000-04 ,pp. : 118-121

Elsevier

Access to resources Recommend Favorite